COMMD4 and breast carcinoma: Taken together, the AS events analyzed in COMMD4_AS2, EXOC7, RHOC, COMMD4_AS1 and POLDIP3 were related to a worse breast cancer prognosis (Fig. 6U), and could constitute potential prognosis biomarkers.